George L. Bakris MD, FASN, FAHAProfessor of Medicine and Director, American Heart Association Comprehensive Hypertension Center, The University of Chicago Medicine, Chicago, Illinois
Dr. Bakris received his medical degree from the Rosalind Franklin Medical School and completed residency in Internal Medicine at the Mayo Graduate School of Medicine where he also completed a research fellowship in Physiology and Biophysics. He then completed fellowships in Nephrology and Clinical Pharmacology at the University of Chicago. From 1988 to 1991, he served as Director of Renal Research at the Ochsner Clinic and had faculty appointments in the Departments of Medicine and Physiology at Tulane University School of Medicine. He later was Professor and Vice Chairman of Preventive Medicine and Director of the Rush University Hypertension Center in Chicago from 1993 until 2006. Currently, he is a Professor of Medicine and Director of the ASH Comprehensive Hypertension Center in the Department of Medicine at the University of Chicago Medicine.
Dr. Bakris is a consultant for Medtronic and Co-PI of SYMPLICITY HTN-3.
Recent Contributions to PracticeUpdate:
- Sotagliflozin for Type 2 Diabetes and Severe Renal Impairment
- Implications of eGFR Dip Following SGLT2 Inhibitor Initiation on Cardiovascular and Kidney Outcomes
- Association Between RAS Blockade Discontinuation and All-Cause Mortality Among Persons With Low eGFR
- Mortality Outcomes With Intensive Blood Pressure Targets in Chronic Kidney Disease Patients
- Improved Cardiovascular Protection by Initial Two-Drug Fixed-Dose Combination Treatment in Hypertension
- Effect of Achieved Systolic Blood Pressure on Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus
- Catheter-Based Renal Denervation in Patients With Uncontrolled Hypertension in the Absence of Antihypertensive Medications
- MY APPROACH to the Elderly Patient With Resistant Hypertension
- Blood Pressure <120/70 mm Hg Is Associated With Better Renal Outcomes in Type 1 Diabetes
- BP and Cardiovascular/Mortality Risk in Diabetes With Renal Impairment